SEARCH

SEARCH BY CITATION

References

  • BOLAND, B., HIMPENS, B., PAQUES, C., CASTEELS, R. & GILLIS, J.M. (1993). ATP induced-relaxation in the mouse bladder smooth muscle. Br. J. Pharmacol., 108, 749753.
  • BROWN, C., BURNSTOCK, G. & COCKS, T. (1979). Effects of adenosine 5′-triphosphate (ATP) and β-γ-methylene ATP on the rat urinary bladder. Br. J. Pharmacol., 65, 97102.
  • BURNSTOCK, G., DUMSDAY, B. & SMYTHE, A. (1972) Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br. J. Pharmacol., 44, 451461.
  • COMPTON, D.R., RICE, K.C., DE COSTA, B.R., RAZDAN, R.K., MELVIN, L.S., JOHNSON, M.R. & MARTIN, B.R. (1993). Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther., 265, 218226.
  • COLQUHOUN, D. (1971). Lectures on Biostatistics. Oxford: Oxford University Press.
  • DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 19461949.
  • FELDER, C.C., JOYCE, K.E., BRILEY, E.M., MANSOURI, J., MACKIE, K., BLOND, O., LAI, Y., MA, A.L. & MITCHELL, R.L. (1995). Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol. Pharmacol., 48, 443450.
  • FELDER, C.C., VELUZ, J.S., WILLIAMS, H.L., BRILEY, E.M. & MATSUDA, L.A. (1992). Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol., 42, 838845.
  • HERKENHAM, M., LYNN, A.B., DE COSTA, B.R. & RICHFIELD, E.K. (1991). Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res., 547, 267274.
  • HERKENHAM, M., LYNN, A.B., LITTLE, M.D., JOHNSON, M.R., MELVIN, L.S., DE COSTA, B.R. & RICE, K.C. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A., 87, 19321936.
  • HILLARD, C.J., EDGEMOND, W.S. & CAMPBELL, W.B. (1995). Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. J. Neurochem., 64, 677683.
  • KENAKIN, T.P. (1993). Pharmacologic Analysis of Drug-Receptor Interaction p. 310. Second Edition. New York: Raven Press.
  • LEFF, P. (1995). The two-state model of receptor activation. Trends Pharmacol. Sci., 16, 8997.
  • MARTYN, C.N., ILLIS, L.S. & THOM, J. (1995). Nabilone in the treatment of multiple sclerosis. Lancet, 345, 579.
  • MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMSKY, M., KAMINSKI, N.E., SCHATZ, A.R., GOPHER, A., ALMOG, S., MARTIN, B.R., COMPTON, D.R., PERTWEE, R.G., GRIFFIN, G., BAYEWITCH, M., BARG, J. & VOGEL, Z. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 8390.
  • MECHOULAM, R. & FRIDE, E. (1995). The unpaved road to the endogenous brain cannabinoid ligands, the anandamides. In Cannabinoid Receptors. ed. Pertwee, R.G. pp. 233258. London: Academic Press.
  • PACHECO, M., CHILDERS, S.R., ARNOLD, R., CASIANO, F. & WARD, S.J. (1991). Aminoalkylindoles: actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther., 257, 170183.
  • PATERSON, S.J. & PERTWEE, R.G. (1993). Characterization of the cannabinoid binding site in the guinea-pig. Br. J. Pharmacol., 109, 82P.
  • PERTWEE, R.G. (1990). The central neuropharmacology of psychotropic cannabinoids. In International Encyclopedia of Pharmacology and Therapeutics, Section 130, Psychotropic Drugs of Abuse. ed. Balfour, D.J.K. pp. 355429. New York: Pergamon Press.
  • PERTWEE, R.G. (1995). Pharmacological, physiological and clinical implications of the discovery of cannabinoid receptors: an overview. In Cannabinoid Receptors. ed. Pertwee, R.G. pp. 134. London: Academic Press.
  • PERTWEE, R.G. & GRIFFIN, G. (1995). A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens. Eur. J. Pharmacol., 272, 6772.
  • PERTWEE, R.G., GRIFFIN, G., FERNANDO, S., LI, X., HILL, A. & MAKRIYANNIS, A. (1995a). AM630, a competitive cannabinoid receptor antagonist. Life Sci., 56, 19491955.
  • PERTWEE, R.G., GRIFFIN, G., LAINTON, J.A.H. & HUFFMAN, J.W. (1995b). Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur. J. Pharmacol., 284, 241247.
  • PERTWEE, R.G., FERNANDO, S.R., NASH, J.E. & COUTTS, A.A. (1996a). Further evidence for the presence of cannabinoid CB2 receptors in guinea-pig small intestine. Br. J. Pharmacol. (in press).
  • PERTWEE, R.G., JOE-ADIGWE, G. & HAWKSWORTH, G.M. (1996b). Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens. Eur. J. Pharmacol. 296, 169172.
  • PERTWEE, R.G., STEVENSON, L.A., ELRICK, D.B., MECHOULAM, R. & CORBETT, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980984.
  • PERTWEE, R.G., STEVENSON, L.A., FERNANDO, S.R. & CORBETT, A.D. (1993). In vitro effects of the cannabinoid, CP 55,940, and of its (+)-enantiomer, CP 56,667. In Problems of Drug Dependence, 1992: Proceeding of the 54th Annual Scientific Meeting of the College on Problems of Drug Dependence, Inc.: National Institute on Drug Abuse Research Monograph Series, Research Monograph 132. ed. Harris, L. p. 374. Rockville, MD: National Institute on Drug Abuse.
  • RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J.C. & DE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letts., 350, 240244.
  • SLIPETZ, D.M., O'NEILL, G.P., FAVREAU, L., DUFRESNE, C., GALLANT, M., GAREAU, Y., GUAY, D., LABELLE, M. & METTERS, K.M. (1995). Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol. Pharmacol., 48, 352361.
  • TALLARIDA, R.J., COWAN, A. & ADLER, A.W. (1979). pA2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci., 25, 637654.